Trinity Biotech Announces Quarter 2 Financial Results EPS of 20 Cents Per ADR -- an Increase of 11%

DUBLIN, Ireland, July 12, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2012.

Back to news